Consider these 5 takeaways from a pharmacy leader in an academic health care system during the COVID-19 crisis.
May 2020
At minimum, they should engage in compliance risks; financial opportunities; key advocacy efforts; and program resources, structure, and value.
Pharmacists address proper dosing of anticoagulants in CAD and PAD In a Pharmacy Times® Insights series, 2 experts agree that communication is incredibly valuable when discussing guidelines and recommendations.
Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.
New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.
While navigating the COVID-19 crisis, organizations should review their game plan for future emergencies.
New approaches present both opportunities and challenges, and pharmacists must stay up-to-date on the latest studies.
The bigger question is how patients can use that information to positively affect their lives.
Advertisement
Advertisement
Trending on Pharmacy Times
1
G-CSF is a Potential Alternative in Treatment of Hot Flashes in Postmenopausal Women
2
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
3
Immunization and Vigilance: Preventing Infections in T-Cell Modifying Therapies
4
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
5
